Prostate Cancer Risk Not Elevated with Testosterone Replacement
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
In fact, men on testosterone replacement therapy (TRT) had a lower PCa rate than men not on TRT.
Data support prophylactic use of a PDE-5 inhibitor in men receiving radiotherapy for prostate cancer.
This approach can reduce adverse events without impairing efficacy.
Collagenase injections decrease penile curvature and eases symptom bother, data show.
Many men even experience an improvement in lower urinary tract symptoms.
Tadalafil plus finasteride improved symptoms scores better than finasteride plus placebo.
Increased prophylaxis may benefit patients with non-O blood type.
Study finds a significant inverse association between weight changes and incontinence scores in normal-weight patients.
Lower urinary tract symptoms alone should raise suspicion for the malignancy.
From 2006-2009, the number of visits rose by an estimated 3.46% annually.